The newly opened facility will support the rapid launch and commercial manufacturing of KSI-301, Kodiak’s investigational retinal disease therapeutic.
List view / Grid view
wet age-related macular degeneration
NICE has issued final guidance recommending Beovu (brolucizumab) to treat wet age-related macular degeneration in adults.
An external review of the medicine Beovu has been announced by Novartis, which produces the drug, according to a new report.